NeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsFeverTaxoidsChemotherapy, AdjuvantDrug Administration ScheduleGranulocyte Colony-Stimulating FactorTreatment OutcomeCisplatinAntineoplastic AgentsPaclitaxelDoxorubicinNeoplasmsCyclophosphamideInfusions, IntravenousDeoxycytidineVinblastineDisease-Free SurvivalSurvival AnalysisCombined Modality TherapyAntineoplastic Agents, PhytogenicCamptothecinLung NeoplasmsCarboplatinAgranulocytosisBreast NeoplasmsMaximum Tolerated DoseSurvival RateEtoposideNeoplasm StagingFever of Unknown OriginOrganoplatinum CompoundsIfosfamideMycosesThrombocytopeniaHematologic DiseasesNeoadjuvant TherapyHematologic NeoplasmsDose-Response Relationship, DrugNeoplasm MetastasisLeukopeniaFluorouracilCarcinoma, Non-Small-Cell LungNauseaAnthracyclinesEpirubicinAntimetabolites, AntineoplasticBacterial InfectionsSalvage TherapyProspective StudiesNeoplasm Recurrence, LocalPrognosisLymphoma, Non-HodgkinAnti-Bacterial AgentsMethotrexateOpportunistic InfectionsDrug Resistance, NeoplasmMucositisAntibiotic ProphylaxisImmunocompromised HostVomitingOxonic AcidTegafurAdenocarcinomaPenicillanic AcidMitoxantroneLeucovorinTime FactorsAdministration, OralDisease ProgressionLeukocyte CountAntineoplastic Agents, AlkylatingOvarian NeoplasmsFollow-Up StudiesBleomycinPlatinum CompoundsDrug-Related Side Effects and Adverse ReactionsAntibiotics, AntineoplasticFeasibility StudiesBacteremiaKaplan-Meier EstimateTopotecanBridged CompoundsRecombinant ProteinsGuanineAlopeciaAntibodies, Monoclonal, HumanizedVincristineStomach NeoplasmsPiperacillinColorectal NeoplasmsAntifungal AgentsAmikacinStomatitisInfectionInduction ChemotherapyAntibodies, Monoclonal, Murine-DerivedRecurrence